|
CCNB2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.6304735339645E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.53460039015374E-10 |
| Normal-vs-Stage2 |
2.25619999999482E-05 |
| Normal-vs-Stage3 |
1.52579999967983E-07 |
| Normal-vs-Stage4 |
8.40769999954638E-07 |
| Stage1-vs-Stage2 |
4.768200E-01 |
| Stage1-vs-Stage3 |
1.924360E-02 |
| Stage1-vs-Stage4 |
5.007400E-04 |
| Stage2-vs-Stage3 |
1.452200E-01 |
| Stage2-vs-Stage4 |
2.020100E-03 |
| Stage3-vs-Stage4 |
2.486300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.63324909152607E-12 |
| Normal-vs-AfricanAmerican |
9.446300E-04 |
| Normal-vs-Asian |
1.289380E-01 |
| Caucasian-vs-AfricanAmerican |
1.595870E-02 |
| Caucasian-vs-Asian |
5.367400E-01 |
| AfricanAmerican-vs-Asian |
3.427200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.58459920132736E-12 |
| Normal-vs-Female |
7.58240137344046E-11 |
| Male-vs-Female |
6.228100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.044400E-04 |
| Normal-vs-Age(41-60Yrs) |
2.34010000266238E-08 |
| Normal-vs-Age(61-80Yrs) |
7.31525950925516E-13 |
| Normal-vs-Age(81-100Yrs) |
5.239400E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.250400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.896600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.180590E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.135200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.916600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.577840E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.518100E-03 |
| Normal-vs-Grade 2 |
4.51805259871207E-12 |
| Normal-vs-Grade 3 |
8.56039683583276E-11 |
| Normal-vs-Grade 4 |
2.71190000000754E-06 |
| Grade 1-vs-Grade 2 |
7.421800E-04 |
| Grade 1-vs-Grade 3 |
3.93830000000595E-06 |
| Grade 1-vs-Grade 4 |
7.79470000000781E-05 |
| Grade 2-vs-Grade 3 |
1.056340E-02 |
| Grade 2-vs-Grade 4 |
7.184100E-04 |
| Grade 3-vs-Grade 4 |
7.362800E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.33040000016571E-07 |
| Normal-vs-ccB subtype |
7.32930383051666E-11 |
| ccA subtype-vs-ccB subtype |
1.55762999999309E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.63169999733981E-09 |
| Normal-vs-N1 |
2.564500E-04 |
| N0-vs-N1 |
9.356200E-03 |
|
|
